v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net Income      
Net Income $ (58,000,000.0) $ 144,200,000 $ 128,100,000
Operating Activities      
Depreciation and amortization 45,800,000 47,600,000 45,100,000
Amortization of deferred financing costs 1,400,000 1,500,000 1,400,000
Deferred income taxes (1,500,000) (8,200,000) (1,100,000)
Restructuring Charges 38,400,000 22,600,000 0
Impairment of Long-Lived Assets Held-for-use   22,600,000 0
Stock-based compensation 7,500,000 23,600,000 29,300,000
Dividends from unconsolidated affiliates 8,000,000.0 4,400,000 10,500,000
Other non-current liabilities 6,300,000 13,800,000 15,100,000
Other 11,000,000.0 18,900,000 20,700,000
Accounts receivable 25,300,000 (14,200,000) 26,800,000
Inventories 156,600,000 35,300,000 (4,300,000)
Other current assets 4,000,000.0 2,800,000 (8,400,000)
Accounts payable (79,900,000) (55,900,000) (81,400,000)
Other liabilities (78,800,000) (65,700,000) (31,100,000)
Net cash provided by operating activities 86,100,000 170,700,000 150,700,000
Investing Activities      
Expenditures for property, plant and equipment (62,500,000) (47,800,000) (35,400,000)
Purchase of noncontrolling interest 0 0 (3,200,000)
Business acquisitions, net of cash acquired 2,600,000 2,200,000 0
Proceeds from sale of assets 2,400,000 1,800,000 1,900,000
Proceeds from Sales of Business, Affiliate and Productive Assets 0 600,000 1,100,000
Proceeds from Sale of Debt Securities, Available-for-sale   0 1,100,000
Net cash used for investing activities (62,700,000) (47,600,000) (34,500,000)
Financing Activities      
Additions to long-term debt 148,400,000 168,900,000 138,800,000
Reductions of long-term debt (171,100,000) (198,500,000) (161,100,000)
Net additions (reductions) to revolving credit agreements 55,200,000 (31,200,000) (53,700,000)
Cash dividends paid (25,400,000) (24,000,000.0) (22,300,000)
Payments of Ordinary Dividends, Noncontrolling Interest (1,300,000) (1,300,000) (1,300,000)
Financing fees paid (2,100,000) 0 (800,000)
Payments for Repurchase of Common Stock (4,500,000) (14,000,000.0) 0
Other financing activities 0 0 (100,000)
Net cash provided by (used for) financing activities (800,000) (100,100,000) (100,500,000)
Cash and Cash Equivalents      
Increase (decrease) for the year 26,600,000 17,800,000 19,800,000
Balance at the beginning of the year 96,600,000 78,800,000 59,000,000.0
Balance at the end of the year 123,200,000 96,600,000 78,800,000
Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation $ 4,000,000.0 $ (5,200,000) $ 4,100,000